The Indian Practitioner

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Outpatient Management: Outcome in Patients with Moderate to Severe Acute Respiratory Syndrome Corona Virus-2 Infection


Affiliations
1 Nephrology, R C Multispeciality Hospital and Trauma Centre, Kiratpur Road, Bijnor 246701, India
2 R C Multispeciality Hospital and Trauma Centre, Kiratpur Road, Bijnor, India
     

   Subscribe/Renew Journal


Introduction: The objective of this study was to understand the effectiveness of the early outpatient treatment of patients with CT-confirmed moderate to severe SARS-CoV-2 infection.

Methods: This is an observational, retrospective study in COVID-19 patients followed from March to May 2021 who visited the clinic as outpatients. Among these, we included adult outpatients who presented approximately within 1 week of onset of symptoms suggestive of SARS-CoV-2 infection and confirmed by high resolution computed tomography (HRCT). The oxygen saturation (SpO2) levels considered for inclusion were <94%, further categorized into a moderate and severe infection. Patients were also radiologically categorized as having a mild, moderate, or severe disease based on computed tomography severity score (CTSS).

Results: Of 200 patients, based on the SpO2 levels and availability of HRCT reports, we included data of 46 patients for analysis. These data included 29 males (63.04%) and 17 females (36.96%), with a mean age of 51.13±14.03 years. Almost 63% of these patients had ≥1 co-morbidity, most commonly, renal diseases. All the patients had been administered treatment within 6 hours of presentation and followed up for 21 days. Of the 46, 10.87% (n=5) patients had a fatal outcome all with the severe disease based on clinical criteria. The mortality rate in patients with SpO2 <90% was 13.88%, while with SpO2 >90 there were no deaths.

Conclusions: Severe hypoxia in patients with co-morbidities is important factor associated with mortality. Multiple comorbid conditions are significantly associated with mortality. CTSS does not necessarily correlate with mortality or hypoxia level. Even in severe cases with SpO2 <90% recovery is possible in most patients with early initiation of therapy.



Keywords

Oxygen Saturation, Computed Tomography Severity Score, SARS-CoV-2
Subscription Login to verify subscription
User
Notifications
Font Size


  • Worldometer. COVID-19 coronavirus pandemic [Internet]. 2021; published online April 10. Available from:https:// www.worldometers.info/coronavirus/(accessed April 12, 2021).

  • Kar SK, Ransing R, Arafat SMY, Menon V. Second wave of COVID-19 pandemic in India: Barriers to effective governmental response. EClinicalMedicine. 2021;36:100915. doi: 10.1016/j.eclinm.2021.100915.

  • Turk C, Turk S, Malkan UY, Haznedaroglu IC. Three critical clinicobiological phases of the human SARS-associated coronavirus infections. Eur Rev Med Pharmacol Sci. 2020;24(16):8606-8620. doi: 10.26355/eurrev_202008_22660.

  • Vaduganathan M, van Meijgaard J, Mehra MR, Joseph J, O’Donnell CJ, Warraich HJ. Prescription fill patterns for commonly used drugs during the COVID-19 pandemic in the United States. JAMA. 2020;323(24):2524–6. https://doi.org/10.1001/jama.2020.9184.

  • McCullough PA, Kelly RJ, Ruocco G, Lerma E, Tumlin J, Wheelan KR, et al. Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. Am J Med. 2021;134(1):16-22. doi: 10.1016/j.amjmed.2020.07.003.

  • Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020;295(3):715-721. doi: 10.1148/radiol.2020200370.

  • Caputo ND, Strayer RJ, Levitan R. Early self-proning in awake, non-intubated patients in the emergency department: a single ED’s experience during the COVID-19 pandemic. Acad Emerg Med. 2020;27(5):375–8.

  • Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, Kara T, Somers VK. Association Between Hypoxemia and Mortality in Patients With COVID-19. Mayo Clin Proc. 2020;95(6):11381147. doi: 10.1016/j.mayocp.2020.04.006. Epub 2020 Apr 11. PMID: 32376101; PMCID: PMC7151468.

  • Bahl A, Van Baalen MN, Ortiz L, Chen NW, Todd C, Milad M, Yang A, Tang J, Nygren M, Qu L. Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort. Intern Emerg Med. 2020;15(8):1485-1499. doi: 10.1007/s11739-020-02509-7. Epub 2020 Sep 24. PMID: 32970246; PMCID: PMC7512216.

  • ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021;36(1):87-94. doi: 10.1093/ndt/gfaa314. PMID: 33340043; PMCID: PMC7771976.

  • Mallett S, Allen AJ, Graziadio S, Taylor SA, Sakai NS, Green K, et al. At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data. BMC Med. 2020 Nov 4;18(1):346. doi: 10.1186/s12916-020-01810-8. PMID: 33143712; PMCID: PMC7609379.

  • Burhan E, Prasenohadi P, Rogayah R, Isbaniyah F, Reisa T, Dharmawan I. Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Timetopositivity, and Potential Role of Chest CT-scan. Acta Med Indones. 2020;52(1):80-83. PMID: 32291376.

  • Bunawan NC, Mokoagow MI, Djojo AY, Wistriany N, Nugroho HM, Harlivasari AD, Diponegoro S. Delayed RT-PCR Time-To-Positivity in an adult with SARS-CoV-2 Infection. J Infect Dev Ctries. 2021;15(7):913-917. doi: 10.3855/ jidc.14766. PMID: 34343115.

  • Aalinezhad M, Alikhani F, Akbari P, Haji Rezaei M, Soleimani S, Hakamifard A. Relationship between CT Severity Score and Capillary Blood Oxygen Saturation in Patients with COVID-19 Infection. Indian J Crit Care Med. 2021;25(3):279–283.

  • Wang K, Kang S, Tian R et al. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area. Clin Radiol.2020;75(5):341–347

  • Dai H, Zhang X, Xia J et al. High-resolution chest CT features and clinical characteristics of patients infected with COVID-19 in Jiangsu, China. Int J Infect Dis.2020;95:106–112

  • Yang R, Li X, Liu H, Zhen Y, Zhang X, Xiong Q, Luo Y, Gao C, Zeng W. Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19. Radiol Cardiothorac Imaging. 2020;2(2):e200047. doi: 10.1148/ryct.2020200047.

  • Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39:1011–1019

  • Bialek S, Boundy E, Bowen V, Chow N, Cohn A, Dowling N, et al. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:343–6.

  • Szente Fonseca SN, de Queiroz Sousa A, Wolkoff AG, Moreira MS, Pinto BC, Valente Takeda CF, Rebouças E, Vasconcellos Abdon AP, Nascimento ALA, Risch HA. Risk of hospitalization for Covid-19 outpatients treated with various drug regimens in Brazil: Comparative analysis. Travel Med Infect Dis. 2020 Nov-Dec;38:101906. doi: 10.1016/j.tmaid.2020.101906.

  • Castro M.M., Kandasamy A.D., Youssef N., Schulz R. Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases. Pharmacol Res. 2011. doi:10.1016/j.phrs.2011.05.005.

  • Shih RD, Maki DG, Hennekens CH. Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven. Contemp Clin Trials Commun. 2020;20:100663. doi: 10.1016/j.conctc.2020.100663. Epub 2020 Oct 7. PMID: 33043163; PMCID: PMC7538864.

  • Stone JH, Frigault MJ, Serling-Boyd NJ, et al. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020;383(24):2333-2344. doi:10.1056/NEJMoa2028836

  • Early Heparin Treatment Linked to LowerCOVID-19 Mortality - Medscape - Jul 15, 2021. 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID): Abstract 1038. Presented July 9, 2021.


Abstract Views: 204

PDF Views: 0




  • Outpatient Management: Outcome in Patients with Moderate to Severe Acute Respiratory Syndrome Corona Virus-2 Infection

Abstract Views: 204  |  PDF Views: 0

Authors

Neha Jain
Nephrology, R C Multispeciality Hospital and Trauma Centre, Kiratpur Road, Bijnor 246701, India
Mudit Agarwal
R C Multispeciality Hospital and Trauma Centre, Kiratpur Road, Bijnor, India

Abstract


Introduction: The objective of this study was to understand the effectiveness of the early outpatient treatment of patients with CT-confirmed moderate to severe SARS-CoV-2 infection.

Methods: This is an observational, retrospective study in COVID-19 patients followed from March to May 2021 who visited the clinic as outpatients. Among these, we included adult outpatients who presented approximately within 1 week of onset of symptoms suggestive of SARS-CoV-2 infection and confirmed by high resolution computed tomography (HRCT). The oxygen saturation (SpO2) levels considered for inclusion were <94%, further categorized into a moderate and severe infection. Patients were also radiologically categorized as having a mild, moderate, or severe disease based on computed tomography severity score (CTSS).

Results: Of 200 patients, based on the SpO2 levels and availability of HRCT reports, we included data of 46 patients for analysis. These data included 29 males (63.04%) and 17 females (36.96%), with a mean age of 51.13±14.03 years. Almost 63% of these patients had ≥1 co-morbidity, most commonly, renal diseases. All the patients had been administered treatment within 6 hours of presentation and followed up for 21 days. Of the 46, 10.87% (n=5) patients had a fatal outcome all with the severe disease based on clinical criteria. The mortality rate in patients with SpO2 <90% was 13.88%, while with SpO2 >90 there were no deaths.

Conclusions: Severe hypoxia in patients with co-morbidities is important factor associated with mortality. Multiple comorbid conditions are significantly associated with mortality. CTSS does not necessarily correlate with mortality or hypoxia level. Even in severe cases with SpO2 <90% recovery is possible in most patients with early initiation of therapy.



Keywords


Oxygen Saturation, Computed Tomography Severity Score, SARS-CoV-2

References